Alnylam Pharmaceuticals, Inc.
Public
ALNY
SectorHealthcare
CountryUnited States
Market cap40.61B
Alnylam Pharmaceuticals, Inc.,"A biopharmaceutical leader in the discovery and development of RNA interference (RNAi) therapeutics for genetically defined and infectious diseases."
